“Organ‐on‐a‐chip” systems integrate microengineering, microfluidic technologies, and
biomimetic principles to create key aspects of living organs faithfully, including critical …

The present review article intends to direct attention to the technological advances made
since 2009 in the area of genipin-crosslinked chitosan (GEN-chitosan) hydrogels. After a …

Recent advances in biomedical technologies are mostly related to the convergence of
biology with microengineering. For instance, microfluidic devices are now commonly found …

In vitro models of skeletal muscle are critically needed to elucidate disease mechanisms,
identify therapeutic targets and test drugs pre-clinically. However, culturing skeletal muscle …

Genipin is a fully assessed non-cytotoxic crosslinking compound. The chitosan| genipin
physical properties such as morphology, roughness, porosity, hydrophilicity, ζ-potential …

Vascular smooth muscle cells' primary function is to maintain vascular homeostasis through
active contraction and relaxation. In diseases such as hypertension and atherosclerosis, this …

A professional guide to 3D and 4D printing technology in the biomedical and
pharmaceutical fields 3D and 4D Printing in Biomedical Applications offers an authoritative …

Organ-on-chip platforms aim to improve preclinical models for organ-level responses to
novel drug compounds. Heart-on-a-chip assays in particular require tissue engineering …

Cardiovascular diseases (CVDs) are the leading cause of death in the western world. With
the current development of clinical diagnostics to more accurately measure the extent and …

Direct detection and analysis of biomolecules and cells in physiological microenvironment is
urgently needed for fast evaluation of biology and pharmacy. The past several years have …